Non-Invasive Quantification of Cartilage Using a Novel In Vivo Bioluminescent Reporter Mouse.

PLoS One

Molecular Biosciences Program, Montana State University, Bozeman, MT, United States of America; Department of Mechanical and Industrial Engineering, Montana State University, Bozeman, MT, United States of America; Department of Cell Biology and Neuroscience, Affiliate Faculty, Montana State University, Bozeman, MT, United States of America.

Published: April 2016

AI Article Synopsis

  • Mouse models are essential for studying post-traumatic osteoarthritis (OA), but tracking cartilage deterioration over time in the same mouse is challenging.
  • A new transgenic mouse model was created with a luciferase reporter under control of the aggrecan promoter, allowing for non-invasive monitoring of cartilage loss.
  • The study linked the reduction in bioluminescence to actual cartilage degradation across different conditions, suggesting this model can effectively quantify cartilage loss in OA research.

Article Abstract

Mouse models are common tools for examining post-traumatic osteoarthritis (OA), which involves cartilage deterioration following injury or stress. One challenge to current mouse models is longitudinal monitoring of the cartilage deterioration in vivo in the same mouse during an experiment. The objective of this study was to assess the feasibility for using a novel transgenic mouse for non-invasive quantification of cartilage. Chondrocytes are defined by expression of the matrix protein aggrecan, and we developed a novel mouse containing a reporter luciferase cassette under the inducible control of the endogenous aggrecan promoter. We generated these mice by crossing a Cre-dependent luciferase reporter allele with an aggrecan creERT2 knockin allele. The advantage of this design is that the targeted knockin retains the intact endogenous aggrecan locus and expresses the tamoxifen-inducible CreERT2 protein from a second IRES-driven open reading frame. These mice display bioluminescence in the joints, tail, and trachea, consistent with patterns of aggrecan expression. To evaluate this mouse as a technology for non-invasive quantification of cartilage loss, we characterized the relationship between loss of bioluminescence and loss of cartilage after induction with (i) ex vivo collagenase digestion, (ii) an in vivo OA model utilizing treadmill running, and (iii) age. Ex vivo experiments revealed that collagenase digestion of the femur reduced both luciferase signal intensity and pixel area, demonstrating a link between cartilage degradation and bioluminescence. In an in vivo model of experimental OA, we found decreased bioluminescent signal and pixel area, which correlated with pathological disease. We detected a decrease in both bioluminescent signal intensity and area with natural aging from 2 to 13 months of age. These results indicate that the bioluminescent signal from this mouse may be used as a non-invasive quantitative measure of cartilage. Future studies may use this reporter mouse to advance basic and preclinical studies of murine experimental OA with applications in synovial joint biology, disease pathogenesis, and drug delivery.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495059PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0130564PLOS

Publication Analysis

Top Keywords

non-invasive quantification
12
quantification cartilage
12
bioluminescent signal
12
mouse
9
cartilage
8
reporter mouse
8
mouse models
8
cartilage deterioration
8
mouse non-invasive
8
endogenous aggrecan
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!